Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
44.22
+0.75 (1.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $4.08 billion as of December 20, 2024. Its market cap has increased by 19.97% in one year.
Market Cap
4.08B
Enterprise Value
4.18B
1-Year Change
19.97%
Ranking
Category
Stock Price
$44.22
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $4.08B, an increase of 243.21%. That is a compound annual growth rate of 11.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 4.08B | 3.99% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PROCEPT BioRobotics | 4.39B |
| Scholar Rock Holding | 4.19B |
| Apellis Pharmaceuticals | 4.13B |
| ADMA Biologics | 4.11B |
| Arcellx | 4.08B |
| Guardant Health | 3.91B |
| Option Care Health | 3.90B |
| Prestige Consumer Healthcare | 3.89B |